- call +1-201-465-4211
- email sales@mrinsights.biz
Allergic contact dermatitis (ACD) is a common inflammatory skin disorder and an alternative form of contact dermatitis. It is manifestation of allergic responses caused by the contact of an allergic substance such as, nickel, gold, chromium, mercaptobenzothiazole, formaldehyde and many more. The other form of contact dermatitis is irritant contact dermatitis (ICD). Symptoms of allergic contact dermatitis (ACDs) are similar to that of irritant contact dermatitis, which makes the diagnosis harder. The symptoms of allergic contact dermatitis include presence of the skin lesion or rashes at the exposure site. Depending on the allergen type, it may form blisters, papules, simple red spots, vesicles and rashes. The rash can drain, ooze or crust and also becomes raw, thickened or scaled. Allergic contact dermatitis (ACD) is caused as a result of two stages, first stage sensitize and primes the immune system for allergic responses and the second stage, triggers it. The diagnosis of allergic contact dermatitis includes physical examination and medical therapy. The precise diagnosis based on the symptoms and by rash appearance is very rare. The intermittent or chronic rashes that are not clarified by historical data and physical examination often requires further testing. A patch test (contact delayed hypersensitivity allergy test) is a normally used to detect the actual cause of allergic contact dermatitis.
Scope of the Report:
This report focuses on the Allergic Contact Dermatitis (ACDS) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The global allergic contact dermatitis (ACDS) market is projected to experience rapid growth with increasing prevalence of the diseases and frequently changing lifestyle. The increased focus for the medical treatment of allergic contact dermatitis with perception of providing a comfortable and healthy life, the global allergic contact dermatitis (ACDS) market is anticipated to increase during the forecast period. The key driver of the global allergic contact dermatitis (ACDS) market is the effectiveness of the treatment by reducing the effect of the symptoms. The Increased government concern and improvement in healthcare sectors are some factors facilitating the growth of allergic contact dermatitis (ACDS) market globally. The scarcity of the qualified specialists, equipped amenities, and other skilled professionals for the treatment of allergic contact dermatitis are few factors responsible for restraining the overall growth of the allergic contact dermatitis (ACDS) market.
The worldwide market for Allergic Contact Dermatitis (ACDS) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Sandoz
Akorn
Perrigo Company
Taro Pharmaceuticals
Teva Pharmaceuticals
Glenmark Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Glucocorticoids
Topical Steroids
Miscellaneous Topical Agents
Corticosteroid
Anticholinergic Antiemetic
Miscellaneous Anxiolytics, Sedatives and Hypnotics
Market Segment by Applications, can be divided into
Topical Administration
Oral Administration
There are 15 Chapters to deeply display the global Allergic Contact Dermatitis (ACDS) market.
Chapter 1, to describe Allergic Contact Dermatitis (ACDS) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Allergic Contact Dermatitis (ACDS), with sales, revenue, and price of Allergic Contact Dermatitis (ACDS), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Allergic Contact Dermatitis (ACDS), for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Allergic Contact Dermatitis (ACDS) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Allergic Contact Dermatitis (ACDS) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Allergic Contact Dermatitis (ACDS) Introduction
1.2 Market Analysis by Type
1.2.1 Glucocorticoids
1.2.2 Topical Steroids
1.2.3 Miscellaneous Topical Agents
1.2.4 Corticosteroid
1.2.5 Anticholinergic Antiemetic
1.2.6 Miscellaneous Anxiolytics, Sedatives and Hypnotics
1.3 Market Analysis by Applications
1.3.1 Topical Administration
1.3.2 Oral Administration
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sandoz
2.1.1 Business Overview
2.1.2 Allergic Contact Dermatitis (ACDS) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sandoz Allergic Contact Dermatitis (ACDS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Akorn
2.2.1 Business Overview
2.2.2 Allergic Contact Dermatitis (ACDS) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Akorn Allergic Contact Dermatitis (ACDS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Perrigo Company
2.3.1 Business Overview
2.3.2 Allergic Contact Dermatitis (ACDS) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Perrigo Company Allergic Contact Dermatitis (ACDS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Taro Pharmaceuticals
2.4.1 Business Overview
2.4.2 Allergic Contact Dermatitis (ACDS) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Taro Pharmaceuticals Allergic Contact Dermatitis (ACDS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Teva Pharmaceuticals
2.5.1 Business Overview
2.5.2 Allergic Contact Dermatitis (ACDS) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Teva Pharmaceuticals Allergic Contact Dermatitis (ACDS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Glenmark Pharmaceuticals
2.6.1 Business Overview
2.6.2 Allergic Contact Dermatitis (ACDS) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Glenmark Pharmaceuticals Allergic Contact Dermatitis (ACDS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Allergic Contact Dermatitis (ACDS) Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Allergic Contact Dermatitis (ACDS) Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Allergic Contact Dermatitis (ACDS) Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Allergic Contact Dermatitis (ACDS) Manufacturer Market Share in 2017
3.3.2 Top 6 Allergic Contact Dermatitis (ACDS) Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Allergic Contact Dermatitis (ACDS) Market Analysis by Regions
4.1 Global Allergic Contact Dermatitis (ACDS) Sales, Revenue and Market Share by Regions
4.1.1 Global Allergic Contact Dermatitis (ACDS) Sales and Market Share by Regions (2013-2018)
4.1.2 Global Allergic Contact Dermatitis (ACDS) Revenue and Market Share by Regions (2013-2018)
4.2 North America Allergic Contact Dermatitis (ACDS) Sales and Growth Rate (2013-2018)
4.3 Europe Allergic Contact Dermatitis (ACDS) Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Allergic Contact Dermatitis (ACDS) Sales and Growth Rate (2013-2018)
4.5 South America Allergic Contact Dermatitis (ACDS) Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Allergic Contact Dermatitis (ACDS) Sales and Growth Rate (2013-2018)
5 North America Allergic Contact Dermatitis (ACDS) by Countries
5.1 North America Allergic Contact Dermatitis (ACDS) Sales, Revenue and Market Share by Countries
5.1.1 North America Allergic Contact Dermatitis (ACDS) Sales and Market Share by Countries (2013-2018)
5.1.2 North America Allergic Contact Dermatitis (ACDS) Revenue and Market Share by Countries (2013-2018)
5.2 United States Allergic Contact Dermatitis (ACDS) Sales and Growth Rate (2013-2018)
5.3 Canada Allergic Contact Dermatitis (ACDS) Sales and Growth Rate (2013-2018)
5.4 Mexico Allergic Contact Dermatitis (ACDS) Sales and Growth Rate (2013-2018)
6 Europe Allergic Contact Dermatitis (ACDS) by Countries
6.1 Europe Allergic Contact Dermatitis (ACDS) Sales, Revenue and Market Share by Countries
6.1.1 Europe Allergic Contact Dermatitis (ACDS) Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Allergic Contact Dermatitis (ACDS) Revenue and Market Share by Countries (2013-2018)
6.2 Germany Allergic Contact Dermatitis (ACDS) Sales and Growth Rate (2013-2018)
6.3 UK Allergic Contact Dermatitis (ACDS) Sales and Growth Rate (2013-2018)
6.4 France Allergic Contact Dermatitis (ACDS) Sales and Growth Rate (2013-2018)
6.5 Russia Allergic Contact Dermatitis (ACDS) Sales and Growth Rate (2013-2018)
6.6 Italy Allergic Contact Dermatitis (ACDS) Sales and Growth Rate (2013-2018)
7 Asia-Pacific Allergic Contact Dermatitis (ACDS) by Countries
7.1 Asia-Pacific Allergic Contact Dermatitis (ACDS) Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Allergic Contact Dermatitis (ACDS) Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Allergic Contact Dermatitis (ACDS) Revenue and Market Share by Countries (2013-2018)
7.2 China Allergic Contact Dermatitis (ACDS) Sales and Growth Rate (2013-2018)
7.3 Japan Allergic Contact Dermatitis (ACDS) Sales and Growth Rate (2013-2018)
7.4 Korea Allergic Contact Dermatitis (ACDS) Sales and Growth Rate (2013-2018)
7.5 India Allergic Contact Dermatitis (ACDS) Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Allergic Contact Dermatitis (ACDS) Sales and Growth Rate (2013-2018)
8 South America Allergic Contact Dermatitis (ACDS) by Countries
8.1 South America Allergic Contact Dermatitis (ACDS) Sales, Revenue and Market Share by Countries
8.1.1 South America Allergic Contact Dermatitis (ACDS) Sales and Market Share by Countries (2013-2018)
8.1.2 South America Allergic Contact Dermatitis (ACDS) Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Allergic Contact Dermatitis (ACDS) Sales and Growth Rate (2013-2018)
8.3 Argentina Allergic Contact Dermatitis (ACDS) Sales and Growth Rate (2013-2018)
8.4 Colombia Allergic Contact Dermatitis (ACDS) Sales and Growth Rate (2013-2018)
9 Middle East and Africa Allergic Contact Dermatitis (ACDS) by Countries
9.1 Middle East and Africa Allergic Contact Dermatitis (ACDS) Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Allergic Contact Dermatitis (ACDS) Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Allergic Contact Dermatitis (ACDS) Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Allergic Contact Dermatitis (ACDS) Sales and Growth Rate (2013-2018)
9.3 UAE Allergic Contact Dermatitis (ACDS) Sales and Growth Rate (2013-2018)
9.4 Egypt Allergic Contact Dermatitis (ACDS) Sales and Growth Rate (2013-2018)
9.5 Nigeria Allergic Contact Dermatitis (ACDS) Sales and Growth Rate (2013-2018)
9.6 South Africa Allergic Contact Dermatitis (ACDS) Sales and Growth Rate (2013-2018)
10 Global Allergic Contact Dermatitis (ACDS) Market Segment by Type
10.1 Global Allergic Contact Dermatitis (ACDS) Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Allergic Contact Dermatitis (ACDS) Sales and Market Share by Type (2013-2018)
10.1.2 Global Allergic Contact Dermatitis (ACDS) Revenue and Market Share by Type (2013-2018)
10.2 Glucocorticoids Sales Growth and Price
10.2.1 Global Glucocorticoids Sales Growth (2013-2018)
10.2.2 Global Glucocorticoids Price (2013-2018)
10.3 Topical Steroids Sales Growth and Price
10.3.1 Global Topical Steroids Sales Growth (2013-2018)
10.3.2 Global Topical Steroids Price (2013-2018)
10.4 Miscellaneous Topical Agents Sales Growth and Price
10.4.1 Global Miscellaneous Topical Agents Sales Growth (2013-2018)
10.4.2 Global Miscellaneous Topical Agents Price (2013-2018)
10.5 Corticosteroid Sales Growth and Price
10.5.1 Global Corticosteroid Sales Growth (2013-2018)
10.5.2 Global Corticosteroid Price (2013-2018)
10.6 Anticholinergic Antiemetic Sales Growth and Price
10.6.1 Global Anticholinergic Antiemetic Sales Growth (2013-2018)
10.6.2 Global Anticholinergic Antiemetic Price (2013-2018)
10.7 Miscellaneous Anxiolytics, Sedatives and Hypnotics Sales Growth and Price
10.7.1 Global Miscellaneous Anxiolytics, Sedatives and Hypnotics Sales Growth (2013-2018)
10.7.2 Global Miscellaneous Anxiolytics, Sedatives and Hypnotics Price (2013-2018)
11 Global Allergic Contact Dermatitis (ACDS) Market Segment by Application
11.1 Global Allergic Contact Dermatitis (ACDS) Sales Market Share by Application (2013-2018)
11.2 Topical Administration Sales Growth (2013-2018)
11.3 Oral Administration Sales Growth (2013-2018)
12 Allergic Contact Dermatitis (ACDS) Market Forecast (2018-2023)
12.1 Global Allergic Contact Dermatitis (ACDS) Sales, Revenue and Growth Rate (2018-2023)
12.2 Allergic Contact Dermatitis (ACDS) Market Forecast by Regions (2018-2023)
12.2.1 North America Allergic Contact Dermatitis (ACDS) Market Forecast (2018-2023)
12.2.2 Europe Allergic Contact Dermatitis (ACDS) Market Forecast (2018-2023)
12.2.3 Asia-Pacific Allergic Contact Dermatitis (ACDS) Market Forecast (2018-2023)
12.2.4 South America Allergic Contact Dermatitis (ACDS) Market Forecast (2018-2023)
12.2.5 Middle East and Africa Allergic Contact Dermatitis (ACDS) Market Forecast (2018-2023)
12.3 Allergic Contact Dermatitis (ACDS) Market Forecast by Type (2018-2023)
12.3.1 Global Allergic Contact Dermatitis (ACDS) Sales Forecast by Type (2018-2023)
12.3.2 Global Allergic Contact Dermatitis (ACDS) Market Share Forecast by Type (2018-2023)
12.4 Allergic Contact Dermatitis (ACDS) Market Forecast by Application (2018-2023)
12.4.1 Global Allergic Contact Dermatitis (ACDS) Sales Forecast by Application (2018-2023)
12.4.2 Global Allergic Contact Dermatitis (ACDS) Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Allergic Contact Dermatitis (ACDS) Picture
Table Product Specifications of Allergic Contact Dermatitis (ACDS)
Figure Global Sales Market Share of Allergic Contact De
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
